US FDA Approves Hearing Loss Therapy of Fennec
The US Food and Drug Administration (FDA) has approved intravenous therapy of Fennec Pharmaceuticals Inc. to prevent chemotherapy-induced hearing loss in children. The new therapy is called Pedmark. The approval, posted on the website of the US FDA, allows it to be used to decrease the risk of ototoxicity in children
Read More